In the United States, there are approximately 17,000 new cases of SCI each year, and roughly 282,000 persons are estimated to be living with SCI.
Males represent the majority of patients with SCI related to a sports injury. The age group with the highest risk of SCI is from 16 to 30 years of age.
Within the US, the leading cause of SCI is motor vehicle collisions, constituting 38% of new SCI each year, while 30% are due to falls, 13% are due to violence, 9% are from sports injuries and 5% are from medical and surgical etiologies.
A Spinal Cord Injury is catastrophic. When a Spinal Cord Injury occurs a permanent scar, called the Glial scar, forms in the spinal cord at the site of the injury in a short period of time after the accident. This Glial scar is permanent and blocks neural signals from the brain travelling down the spinal cord below the point of injury, halting and severely disrupting normal body function and causing numerous profound, severe and in some cases potentially fatal complications.
Damage to any part of the spinal cord or nerves can cause temporary or permanent changes in sensation, movement, strength and body functions below the site of injury. Symptoms of a SCI include:
Traumatic SCI can be classified by two types: complete and incomplete.
There is no cure for a SCI, treatments currently being used today are not effective at treating the injury site Glial scar or returning bodily function, they are more concerned with patient survival initially and adapting to the impacts of the injury such as paralysis thereafter:
Although there is no cure for a SCI, there are many treatments currently being used today:
Immediate Treatment
Long-term Treatment
Looking ahead
These treatments along with newer technologies, may provide people with spinal cord injuries the possibility to lead very productive and rewarding lives. And now, there is an exciting new treatment on the horizon.
In this month’s issue, we introduce NeuroSolv Therapeutics, a Belfast, Northern Ireland and Baltimore, USA based ethical business which has developed and patented Perineline™, a two-part, non-surgical therapy to treat spinal cord injury based upon Neural Signaling Interventions and direct treatment of the Glial scar. The Glial scar is left in the spinal cord after injury, blocking the neural signals to the body. Visit https://www.neurosolvtherapeutics.com for more information.
To learn more NeuroSolv Therapeutics Perineline™ treatment, click here.